GSK Restructuring Signals Belgian Pharma Sector Fragility

GSK announces restructuring in Belgium, citing vulnerability to industry-wide pressures. The move highlights growing fragility in Belgium's pharmaceutical sector, a key economic driver with significant employment and export contributions. Uncertainty remains over the scale of job cuts and potential broader sector impact.